Environmental and Nutritional Diseases III Flashcards
HRT
hormone replacement therapy
-often post-menopausal women
estrogen with progesterone
negative effects of HRT
cancer risk
-breast, endometrial, ovarian
also increased thromboembolsim
HRT and breast cancer
increases risk after 5-8 years of use
HRT and atherosclerosis and coronary disease
beneficial in women under age 60
HRT and thromboembolism
increased risk
- DVT and PEs
- during first 2 years of treatment
- those who are hypercoagulable
- factor V and PT mutations
risks of oral contraceptives
synthetic estradiol and progestin
-currently - lower estrogens and safer
OC and thromboembolism
3x increase in venous thrombosis and pulmonary thromboembolism
increased further with factor V leiden and PT mutations
- consequence if acute-phase response - increased C reactive proteins and coag factors
- also, reduction in anticoag - protein S and antithrombin III
OC and cardiovascular disease
increased risk of MI in smoking women all ages and nonsmoking women over age 35
OC and cancer
reduce endometrial and ovarian cancer
increase in hepatic adenoma**
older women who have used OC for long time
increased risk for hepatic adenoma**
large , solitary, well encapsulated masses
anabolic steroids
synthetic testosterone
inhibit release of LH and FSH
increase amount of estrogens
adverse effects of steroids
stunted growth in adolescent acne gynecomastia testicular atrophy in males facial hair and menstrual changes in females
asthma from drug rxns
salicylates
acute pneumonitis from drug rxns
nitrofurantoin
interstitial fibrosis from drug rxns
bleomycin**
nitrofurantoin
busulfan
tinnitus and dizziness and drug rxns
salicylates
acute dystonic rxns and parkinsonian syndrome and drug rxns
phenothiazine antipsychotics